5
Participants
Start Date
October 25, 2019
Primary Completion Date
August 13, 2021
Study Completion Date
August 13, 2021
Etanercept
Subjects will receive 50 mg of study drug on visit 1. A second dose of study drug will be administered if the pain intensity is ≥ 5 on a pain scale of 0-10 at Visit 2
Triamcinolone Acetonide
Subjects will be administered triamcinolone acetonide 40 mg intramuscularly on visit 1. A second dose of drug will be administered if the pain intensity is ≥ 5 on a pain scale of 0-10 at Visit 2
Rutgers, Robert Wood Johnson Medical School, Clinical Research Center, New Brunswick
Collaborators (1)
Amgen
INDUSTRY
Rutgers, The State University of New Jersey
OTHER